RxDoctor Payments Data

David Kaufman, MD

Critical Care Medicine · Bridgeport, CTNPI 1629000849

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $17,678 of the $20,445 with a category attached, or 86.5%. 9 manufacturers reported payments, led by Roche Diagnostics International Ltd at 35.3% of the total. Reporting peaked in 2019 at $6,348 and has fallen 50.0% since, to $3,171 in 2024. Among critical care medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,445in general payments, 2019–2025

Across 31 payments — averaging $659.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Roche Diagnostics International Ltd$7K
  • Getinge USA Sales, LLC$5K
  • Maquet Cardiovascular L.L.C.$3K
  • Rigel Pharmaceuticals, Inc.$3K
  • Maquet Critical Care AB$2K
  • Vapotherm Inc$184
  • plus $98 from 3 others
$85,563in research payments, 2019–2025

Across 18 payments — averaging $4753.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Dompe Farmaceutici S.p.a.$55K
  • Fisher & Paykel Healthcare Limited$30K

What the payments were for

  • Speaking & faculty fees$17,67886%
  • Travel & lodging$2,21311%
  • Food & beverage$5543%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,445 in reported general payments places this provider in the 90th percentile of 51 critical care medicine providers in Connecticut.

See all critical care medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$74,585
Medicare patients
186
Services billed
475

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Bridgeport

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →